Literature DB >> 16301602

Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.

Bryan A Kraynack1, Brenda F Baker.   

Abstract

RNA interference (RNAi) is a process by which short interfering RNAs (siRNAs) direct the degradation of complementary single-strand RNAs. In this study, we investigated the effects of full-strand phosphorothioate (PS) backbone and 2'-O-methyl (2'-OMe) sugar modifications on RNAi-mediated silencing. In contrast to previous reports, we have identified active siRNA duplexes containing full 2'-OMe-modified sense strands that display comparable activity to the unmodified analog of similar sequence. The structure of these modified siRNAs is the predominant determinant of their activity, with sequence and backbone composition being secondary. We further show, by using biotin-tagged siRNAs and affinity-tagged hAgo2/eIF2C2, that activity of siRNA duplexes containing full 2'-OMe substitutions in the sense strand is mediated by the RNA-induced silencing complex (RISC) and that strand-specific loading (or binding) to hAgo2 may be modulated through selective incorporation of these modifications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301602      PMCID: PMC1370895          DOI: 10.1261/rna.2150806

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  52 in total

1.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  Crystal structure of Argonaute and its implications for RISC slicer activity.

Authors:  Ji-Joon Song; Stephanie K Smith; Gregory J Hannon; Leemor Joshua-Tor
Journal:  Science       Date:  2004-07-29       Impact factor: 47.728

Review 3.  Use of antisense oligonucleotides in functional genomics and target validation.

Authors:  Lingamanaidu V Ravichandran; Nicholas M Dean; Eric G Marcusson
Journal:  Oligonucleotides       Date:  2004

4.  Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs.

Authors:  Hongjiang Wu; Walt F Lima; Hong Zhang; Amy Fan; Hong Sun; Stanley T Crooke
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

5.  In vivo activity of nuclease-resistant siRNAs.

Authors:  Juliana M Layzer; Anton P McCaffrey; Alice K Tanner; Zan Huang; Mark A Kay; Bruce A Sullenger
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

6.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

7.  Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.

Authors:  Peter C Scacheri; Orit Rozenblatt-Rosen; Natasha J Caplen; Tyra G Wolfsberg; Lowell Umayam; Jeffrey C Lee; Christina M Hughes; Kalai Selvi Shanmugam; Arindam Bhattacharjee; Matthew Meyerson; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

8.  A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila.

Authors:  John W Pham; Janice L Pellino; Young Sik Lee; Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

9.  Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways.

Authors:  Young Sik Lee; Kenji Nakahara; John W Pham; Kevin Kim; Zhengying He; Erik J Sontheimer; Richard W Carthew
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

10.  Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.

Authors:  Jens Harborth; Sayda M Elbashir; Kim Vandenburgh; Heiko Manninga; Stephen A Scaringe; Klaus Weber; Thomas Tuschl
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2003-04
View more
  36 in total

1.  Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

Authors:  Aimee L Jackson; Julja Burchard; Devin Leake; Angela Reynolds; Janell Schelter; Jie Guo; Jason M Johnson; Lee Lim; Jon Karpilow; Kim Nichols; William Marshall; Anastasia Khvorova; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

Review 2.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 3.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

4.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs.

Authors:  Michael A Collingwood; Scott D Rose; Lingyan Huang; Chris Hillier; Mohammad Amarzguioui; Merete T Wiiger; Harris S Soifer; John J Rossi; Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-06

5.  Fluorescence cross-correlation spectroscopy reveals mechanistic insights into the effect of 2'-O-methyl modified siRNAs in living cells.

Authors:  Thomas Ohrt; Wolfgang Staroske; Jörg Mütze; Karin Crell; Markus Landthaler; Petra Schwille
Journal:  Biophys J       Date:  2011-06-22       Impact factor: 4.033

6.  Improving gene silencing of siRNAs via tricyclo-DNA modification.

Authors:  Damian Ittig; Samuel Luisier; Jan Weiler; Daniel Schümperli; Christian J Leumann
Journal:  Artif DNA PNA XNA       Date:  2010-07

Review 7.  Relating Structure and Dynamics in RNA Biology.

Authors:  Kevin P Larsen; Junhong Choi; Arjun Prabhakar; Elisabetta Viani Puglisi; Joseph D Puglisi
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

8.  Automated solid-phase synthesis of RNA oligonucleotides containing a nonbridging phosphorodithioate linkage via phosphorothioamidites.

Authors:  Nan-Sheng Li; John K Frederiksen; Joseph A Piccirilli
Journal:  J Org Chem       Date:  2012-10-25       Impact factor: 4.354

9.  Probing the inherent stability of siRNA immobilized on nanoparticle constructs.

Authors:  Stacey N Barnaby; Andrew Lee; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-19       Impact factor: 11.205

10.  Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing.

Authors:  Glen F Deleavey; Jonathan K Watts; Tommy Alain; Francis Robert; Anna Kalota; Veenu Aishwarya; Jerry Pelletier; Alan M Gewirtz; Nahum Sonenberg; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2010-04-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.